D
David M. Mirvis
Researcher at University of Tennessee Health Science Center
Publications - 152
Citations - 5150
David M. Mirvis is an academic researcher from University of Tennessee Health Science Center. The author has contributed to research in topics: Health care & Coronary artery disease. The author has an hindex of 30, co-authored 152 publications receiving 4798 citations. Previous affiliations of David M. Mirvis include United States Department of Veterans Affairs & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Recommendations for the Standardization and Interpretation of the Electrocardiogram
Paul Kligfield,Leonard S. Gettes,James J. Bailey,Rory Childers,Barbara J. Deal,E. William Hancock,Gerard van Herpen,Jan A. Kors,Peter W. Macfarlane,David M. Mirvis,Olle Pahlm,Pentti M. Rautaharju,Galen S. Wagner +12 more
TL;DR: This statement examines the relation of the resting ECG to its technology to establish standards that will improve the accuracy and usefulness of the ECG in practice and to recommend recommendations for ECG standards.
Journal ArticleDOI
Recommendations for the Standardization and Interpretation of the Electrocardiogram: Part I: The Electrocardiogram and Its Technology A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology
Paul Kligfield,Leonard S. Gettes,James J. Bailey,Rory Childers,Barbara J. Deal,E. William Hancock,Gerard van Herpen,Jan A. Kors,Peter W. Macfarlane,David M. Mirvis,Olle Pahlm,Pentti M. Rautaharju,Galen S. Wagner +12 more
TL;DR: This statement examines the relation of the resting ECG to its technology to establish standards that will improve the accuracy and usefulness of the ECG in practice and to recommend recommendations for ECG standards.
Journal ArticleDOI
Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women.
Jay M. Sullivan,Roger Vander Zwaag,Roger Vander Zwaag,Jeff P. Hughes,Jeff P. Hughes,Virginia Maddock,Virginia Maddock,Frank W. Kroetz,Frank W. Kroetz,Kodangudi B. Ramanathan,David M. Mirvis,David M. Mirvis +11 more
TL;DR: It is concluded that estrogen replacement after menopause prolongs survival when coronary artery disease is present, but it has less effect in the absence of coronary arteries disease.
Journal ArticleDOI
Postmenopausal estrogen use and coronary atherosclerosis.
Jay M. Sullivan,Roger Vander Zwaag,George F. Lemp,Jeff P. Hughes,Virginia Maddock,Frank W. Kroetz,K. B. Ramanathan,David M. Mirvis +7 more
TL;DR: The data suggest that postmenopausal estrogen treatment reduces the risk for angiographically significant coronary artery disease.
Journal ArticleDOI
AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram Part V: Electrocardiogram Changes Associated With Cardiac Chamber Hypertrophy: A Scientific Statement From the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: Endorsed by the International Society for Computerized Electrocardiology
E. William Hancock,Barbara J. Deal,David M. Mirvis,Peter M. Okin,Paul Kligfield,Leonard S. Gettes +5 more
TL;DR: The detection and assessment of cardiac chamberhypertrophy has long been an important objective of clinical electrocardiography, but its importance has increased in recent years with the recognition that hypertrophy can be reversed with therapy, and that by doing so, adverse clinical outcomes can be avoided.